Karin Garre

Director/Board Member at EXPRES2ION BIOTECH HOLDING AB

67 year

Health Technology

Transportation

Consumer Services

Profile

Karin Garre is an Independent Director at Expres2ion Biotech Holding AB.
She is also a Director at Cervello A.
Previously, she served as the General Manager at Symphogen A.
Before that, she was the Chief Executive Officer at K:2.
Holding ApS.
She also held the position of Chairman at NTG Nordic Transport Group A from 2013 to 2018.
Additionally, she has experience as a Director at StemCare A, StemCare Danmark A, and Lægernes Test Center A.
Dr. Garre obtained her doctorate degree from the University of Copenhagen in 1983.

Karin Garre active positions

Companies	Position	Start
EXPRES2ION BIOTECH HOLDING AB	Director/Board Member	26/05/2021
Symphogen A/S Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark.	Corporate Officer/Principal	05/06/2020
Cervello A/S	Director/Board Member	-

All active positions of Karin Garre

Former positions of Karin Garre

Companies	Position	End
NTG NORDIC TRANSPORT GROUP A/S	Chairman	14/09/2018
Lægernes Test Center A/S	Director/Board Member	-
StemCare Danmark A/S	Director/Board Member	-
StemCare A/S StemCare A/S BiotechnologyHealth Technology StemCare A/S operates as a private stem cell bank. The firm stores stem cells from umbilical cord blood. The company was founded by Sten Verland in 2003 and is headquartered in Gentofte, Denmark.	Director/Board Member	-
K:2 Holding ApS	Chief Executive Officer	-

See the detail of Karin Garre's experience

Training of Karin Garre

University of Copenhagen

Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Karin Garre's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	2
NTG NORDIC TRANSPORT GROUP A/S	Transportation
EXPRES2ION BIOTECH HOLDING AB	Health Technology

Private companies	6
Symphogen A/S Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark.	Health Technology
StemCare A/S StemCare A/S BiotechnologyHealth Technology StemCare A/S operates as a private stem cell bank. The firm stores stem cells from umbilical cord blood. The company was founded by Sten Verland in 2003 and is headquartered in Gentofte, Denmark.	Health Technology
StemCare Danmark A/S
K:2 Holding ApS
Lægernes Test Center A/S
Cervello A/S

See company connections